Skip to main content

Year: 2022

Nokia Corporation financial calendar for 2023

Nokia CorporationStock Exchange Release1 December 2022 at 8:00 EET Nokia Corporation financial calendar for 2023 Espoo, Finland – In this stock exchange release Nokia provides its financial calendar for 2023, which includes the planned publication dates of its financial reports. Planned publication dates for Nokia’s financial reports in 2023:report for Q4 2022 and full year 2022: 26 January 2023 report for Q1 2023: 20 April 2023 report for Q2 2023 and half-year 2023: 20 July 2023 report for Q3 2023 and January-September 2023: 19 October 2023New preliminary dates for the fourth installment of the shareholder distribution originally announced on 5 April 2022 The new preliminary record date for shareholder distribution following the publication of the report for Q4 2022 is 31 January 2023 and the new preliminary payment date is...

Continue reading

Biotalys Creates Scientific Advisory Committee with Leading Experts

AgTech Innovator Deepens Network of Scientific Leaders in Key Focus Areas to Support Global Expansion Ghent, Belgium, Dec. 01, 2022 (GLOBE NEWSWIRE) — Biotalys (Euronext – BTLS), an Agricultural Technology (AgTech) company protecting crops and food with protein-based biocontrol solutions, today announced the establishment of a Scientific Advisory Committee (SAC) that will support the company’s continued growth, accelerate product pipeline efforts and deepen scientific partnership initiatives. Timed with its official creation, Biotalys also announced the appointment of Dr. Claude Bensoussan, Dr. Hans-Jürgen Rosslenbroich and Dr. Ioannis Stergiopoulos to the SAC. “As we actively scale in preparation for global commercialization, we are committed to bringing together the best scientific minds in the industry to broaden our continued...

Continue reading

Rubicon Organics Releases Second Annual ESG Report

VANCOUVER, British Columbia, Nov. 30, 2022 (GLOBE NEWSWIRE) — Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis, is pleased to announce the publication of its second annual Environmental, Social and Governance Report measuring the year ended December 31, 2021 (“ESG Report”). Rubicon Organics has taken an ESG leadership position in the cannabis sector, being the first cannabis company to issue a report. The ESG Report captures the period between January 1 and December 31, 2021 and reflects the Company’s determination to formally embed sustainability throughout our operations and supply chain. While our targets are ambitious, we are holding ourselves accountable through measuring and reporting our ESG...

Continue reading

Propylene Oxide Market is projected to reach USD 29.5 billion by 2026 Globally, at a CAGR of 5.6%, says MarketsandMarkets™

Chicago, Nov. 30, 2022 (GLOBE NEWSWIRE) — The global propylene oxide market is projected to grow from USD 22.5 billion in 2021 to USD 29.5 billion by 2026, at a CAGR of 5.6% from 2021 to 2026, as per the recent study by MarketsandMarkets™. The propylene oxide market is majorly driven by the rising demand for polyurethanes in various end–use industries, such as automotive, building & construction, textile & furnishing, chemical & pharmaceutical, packaging, and electronics. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=55659975 Browse in-depth TOC on “Propylene Oxide Market” 112 – Market Data Tables 50 – Figures 197 – Pages List of Key Players in Propylene Oxide Market:propylene oxide market. Dow Inc. (US)  LyondellBasell Industries Holdings B.V. (Netherlands)  Royal...

Continue reading

Interfor Completes Acquisition of Chaleur Forest Products and Announces Additional Long Term Debt Financing

BURNABY, British Columbia, Nov. 30, 2022 (GLOBE NEWSWIRE) — INTERFOR CORPORATION (“Interfor” or the “Company”) (TSX: IFP) announced today that it has completed the previously announced transaction to acquire 100% of the equity interests in the entities comprising Chaleur Forest Products (“Chaleur”) in New Brunswick, Canada from an affiliate of the Kilmer Group. Interfor also announced today that it has priced US$200 million in additional long-term debt financing with Prudential Private Capital. The senior secured notes will carry an annual interest rate of 7.06% and have a final maturity in 2033. All other terms remain consistent with Interfor’s existing senior secured notes. The financing is expected to close in early December and the proceeds will be used to finance the Chaleur acquisition and for general corporate purposes. Following...

Continue reading

Edge Total Intelligence Inc. Reports Third Quarter 2022 Results and Provides Operational Outlook

ARLINGTON, Va., Nov. 30, 2022 (GLOBE NEWSWIRE) — Edge Total Intelligence Inc. (TSXV: CTRL, OTC: UNFYF, FSE: Q5i )(“edgeTI”, “we”, “our” or the “Company”), a leader in real-time digital operations, announces operating and consolidated results for the third quarter 2022 (“Q3-2022”). Financial information is expressed in United States (US) dollars unless otherwise indicated. The Company’s related financials and management discussion and analysis for the third quarter, 2022 are posted on its profiles on SEDAR (www.sedar.com) and OTCMarkets (www.otcmarkets.com). Selected Financial Details for Q3-2022Total revenue decreased 10% to $908,064 versus $1,013,403 the quarter ending September 30, 2021 (“Q3-2021”) largely due to intended shift in contracted professional services. Subscription revenue grew slightly to $795,698 versus $793,859...

Continue reading

Onica by Rackspace Technology Achieves the AWS Service Delivery Designation for AWS Glue

SAN ANTONIO, Nov. 30, 2022 (GLOBE NEWSWIRE) — Rackspace Technology® (NASDAQ: RXT) — a leading end-to-end, multicloud technology solutions company, today announced that Onica by Rackspace Technology, the cloud services-focused business group, announced today that it has achieved the Amazon Web Service (AWS) Service Delivery designation for AWS Glue. The AWS Glue Service Delivery designation recognizes that Onica by Rackspace Technology has proven success in helping customers discover consulting partners who have the expertise to deliver AWS Glue for data integration, pipeline, and catalogue use cases. AWS Partners with this designation makes it easy for customers to discover, prepare, and combine data for analytics, machine learning, and application development. AWS Glue provides all the capabilities needed for data integration...

Continue reading

RAPT Therapeutics to Present FLX475 Phase 1/2 Data at the European Society for Medical Oncology (ESMO) Immuno-Oncology Annual Congress

SOUTH SAN FRANCISCO, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT” or the “Company”), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology, today announced that its abstract from its ongoing Phase 1/2 study of FLX475 as monotherapy and in combination with pembrolizumab in cancer patients has been accepted for poster presentation at the European Society for Medical Oncology (ESMO) Immuno-Oncology Annual Congress taking place December 7-9, 2022 in Geneva, Switzerland. The presentation will include data from checkpoint inhibitor-naïve NSCLC patients treated with the combination of FLX475 plus pembrolizumab including their...

Continue reading

Oncocyte Announces Executive Leadership Changes

IRVINE, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) — Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company with the mission to improve patient outcomes by providing personalized insights that inform critical decisions throughout the patient care journey, today announced that Ronnie Andrews will step down from his role as Chief Executive Officer and as a director of the Company’s board of directors effective December 1, 2022. In order to ensure a smooth transition effective as of December 2, 2022, Joshua Riggs will serve as interim Chief Executive Officer until such time as a new CEO has been identified and retained and Mr. Andrews will continue to act a consultant until February 28, 2023. Mr. Riggs, who has been Oncocyte’s General Manager, Transplant since July 2022 and was the Company’s Senior Director Business Development...

Continue reading

Viracta Therapeutics Announces Preliminary Dose-Ranging Data from the Phase 1b/2 Trial of Nana-val in Advanced Epstein-Barr Virus-Positive (EBV+) Solid Tumors at the ESMO Immuno-Oncology Congress

Data from first two dose levels of Nana-val in patients with EBV+ recurrent/metastatic nasopharyngeal carcinoma support continued dose escalation to determine the optimal recommended Phase 2 dose SAN DIEGO, Nov. 30, 2022 (GLOBE NEWSWIRE) — Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide, today reported preliminary dose-ranging data from the first two dose levels of the dose escalation part of the Phase 1b/2 study of Nana-val in patients with EBV+ recurrent/metastatic nasopharyngeal carcinoma (R/M NPC). The data are featured in an abstract accepted for a poster presentation at the European Society for Medical Oncology Immuno-Oncology Congress (ESMO-IO), which is taking place both virtually and in-person at the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.